[1] |
World Health Organization.GlobalHealth Estimates 2020: Deaths by cause, age, sex, by country and by region,2000-2019[EB/OL].[2023-05-12].
URL
|
[2] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249.
|
[3] |
Zhao N, Rosen JM.Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies[J]. Semin Cancer Biol,2022,7(82):3-10.
|
[4] |
Dai X, Cheng H, Bai Z, et al. Breast cancer cell line classification and its relevance with breast tumor subtyping[J]. J Cancer, 2017,8(16):3131-3141.
|
[5] |
Cailleau R, Olivé M, Cruciger QV. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization[J]. In Vitro,1978,14(11):911-915.
|
[6] |
Soule HD, Vasquez J, Long A, et al. A human cell line from a pleural effusion derived from a breast carcinoma[J]. J Natl Cancer Inst, 1973,51(5):1409-1416.
|
[7] |
Levenson AS, Jordan VC. MCF-7: the first hormone-responsive breast cancer cell line[J]. Cancer Res,1997,57(15):3071-3078.
|
[8] |
Lasfargues EY, Ozzello L. Cultivation of human breast carcinomas[J]. J Natl Cancer Inst,1958,21(6):1131-1147.
|
[9] |
Ethier SP, Mahacek ML, Gullick WJ, et al. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media[J]. Cancer Res,1993,53(3):627-635.
|
[10] |
Cope LM, Fackler MJ, Lopez-Bujanda Z, et al. Do breast cancer cell lines provide a relevant model of the patient tumor methylome?[J]. PLoS One,2014,9(8):e105545.
|
[11] |
Lacroix M, Haibe-Kains B, Hennuy B, et al. Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes[J]. Oncol Rep,2004,12(4):701-707.
|
[12] |
Holliday DL, Speirs V. Choosing the right cell line for breast cancer research[J]. Breast Cancer Res,2011,13(4):215.
|
[13] |
Gazdar AF, Kurvari V, Virmani A, et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer[J]. Int J Cancer,1998,78(6):766-774.
|
[14] |
Band V, Zajchowski D, Swisshelm K, et al. Tumor progression in four mammary epithelial cell lines derived from the same patient[J]. Cancer Res,1990,50(22):7351-7317.
|
[15] |
Ethier SP, Mahacek ML, Gullick WJ, et al. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media[J]. Cancer Res,1993,53(3):627-635.
|
[16] |
International Cell Line Authentication Committee(ICLA). Naming a cell line: essential requirements[EB/OL]. [2023-05-12].
URL
|
[17] |
Yu M, Selvaraj SK, Liang-Chu MM, et al. A resource for cell line authentication, annotation and quality control[J]. Nature,2015,520(7547):307-311.
|
[18] |
Siwek B, Larsimont D, Lacroix M, et al. Establishment and characterization of three new breast-cancer cell lines[J]. Int J Cancer,1998,76(5):677-683.
|
[19] |
Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes[J]. Cancer Cell,2006,10(6):515-527.
|
[20] |
Riaz M, van Jaarsveld MT, Hollestelle A, et al. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs[J]. Breast Cancer Res,2013,15(2):R33.
|
[21] |
Bertucci F, Borie N, Ginestier C, et al. Identification and validation of an ERBB2 gene expression signature in breast cancers[J]. Oncogene,2004,23(14):2564-2575.
|
[22] |
Charafe-Jauffret E, Ginestier C, Monville F, et al. Gene expression profiling of breast cell lines identifies potential new basal markers[J]. Oncogene,2006,25(15):2273-2284.
|
[23] |
Kao J, Salari K, Bocanegra M, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery[J]. PLoS One,2009,4(7):e6146.
|
[24] |
Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes[J]. Cancer Cell,2006,10(6):515-527.
|
[25] |
Dai XF, Xiang L,Li T, et al. Cancer hallmarks, biomarkers and breast cancer molecular subtypes[J]. J Cancer,2016, 7: 1281-1294.
|
[26] |
Kurebayashil J, Kurosumi M, Sonoo H. A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice[J]. Br J Cancer,1996,74: 200-207.
|
[27] |
Rye PD, Norum L, Olsens D, et al. Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11[J]. Int J Cancer,1996,68: 682-687.
|
[28] |
Hackenberg R, Luttchens S, Hofmann J, et al. Androgen sensitivity of the new human breast cancer cell line MFM-223[J]. Cancer Res,1991,51: 5722-5727.
|
[29] |
Gioanni J, Le Francois D, Zanghellini E, et al. Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma[J]. Br J Cancer,1990, 62: 8-13.
|
[30] |
Ellison G, Klinowska T, Westwood RF,et al. Further evidence to support the melanocytic origin of MDA-MB-435[J]. Mol Pathol,2002,55(5):294-299.
|
[31] |
Capes-Davis A, Theodosopoulos G, Atkin I, et al. Check your cultures! A list of cross-contaminated or misidentified cell lines[J]. Int J Cancer,2010,127(1):1-8.
|
[32] |
Warso MA, Mehta RR, Hart GD, et al. A cell line derived from a clinically benign phyllodes tumor: characterization and implications[J]. Anticancer Res,1995,15(2):399-404.
|
[33] |
Cheang MC, Voduc D, Bajdik C, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype[J]. Clin Cancer Res,2008,14(5):1368-1376.
|
[34] |
Larramendy ML, Lushnikova T, Björkqvist AM, et al. Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines[J]. Cancer Genet Cytogenet,2000,119(2):132-138.
|
[35] |
Wistuba II, Behrens C, Milchgrub S, et al. Comparison of features of human breast cancer cell lines and their corresponding tumors[J]. Clin Cancer Res,1998,4(12):2931-2938.
|
[36] |
Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis[J]. Oncogene,2002,21(35):5462-5482.
|
[37] |
Ravi M, Sneka MK, Joshipura A. The culture conditions and outputs from breast cancer cell line in vitro experiments[J]. Exp Cell Res,2019,383(2):111548.
|